Clinical Trial Update: Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders [NA]

View source ↗

Summary

A completed clinical trial evaluating the target engagement of a novel dissonance-based treatment for DSM-5 eating disorders conducted by Stanford University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eating Disorders

Snippet

Sponsor: Stanford University | Conditions: Eating Disorder | NA | Status: COMPLETED